CRANE STRATEGIES

Lobbying for REGENERON PHARMACEUTICALS, INC. · Biopharmaceutical development and manufacturing

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $50,000.00 income · posted May 4, 2026

Lobbying activity 1

Budget/Appropriations

Biodefense and Medicare prescription drug funding

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem